Noll Austin Francis III 4
4 · NATUS MEDICAL INC · Filed Jul 21, 2022
Insider Transaction Report
Form 4Exit
Noll Austin Francis III
Executive VP and CCO
Transactions
- Award
Common Stock, $0.001 par value per share
[F1]2022-07-21+61,966→ 200,509 total - Disposition to Issuer
Common Stock, $0.001 par value per share
[F2][F3]2022-07-21$33.50/sh−200,509$6,717,052→ 0 total - Disposition to Issuer
Non-qualified Stock Option
[F4]2022-07-21$12.82/sh−72,534$929,886→ 0 totalExercise: $20.68Exp: 2030-11-13→ Common Stock (72,534 underlying)
Footnotes (4)
- [F1]Represents the number of shares of Common Stock subject to performance-based stock unit awards that vested and were settled as a result of the merger ("Merger") pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc. ("Parent"), Prince Mergerco Inc, and Issuer ("Merger Agreement").
- [F2]Disposed of as a result of the Merger.
- [F3]Each share of Common Stock, including shares underlying equity awards, was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement, subject to applicable tax withholding.
- [F4]This option, which provided for vesting in four equal annual installments beginning November 13, 2021, was cancelled in the Merger pursuant to the Merger Agreement in exchange for a cash payment, per option share, representing the difference between the per share exercise price of the option and the per share cash consideration provided in the Merger Agreement ($33.50), subject to applicable tax withholding.
Signature
/s/ DOUGLAS BALOG by POWER OF ATTORNEY|2022-07-21